Lupin, China’s SUP ink pact for COPD drug Tiotropium DPI

Under the partnership that will enable Lupin to expand footprint in China, SUP will obtain regulatory approvals for selling Tiotropium DPI in China. Lupin will be the marketing authorisation holder and responsible for manufacturing of the product

Industry